Aging populations, poor lifestyles/diets & chronic disease go hand-in-hand.
Moreover, fewer people nowadays are taking responsibility for their own healthcare. Instead becoming increasingly reliant on overburdened organisations like the NHS.
So what’s the solution?
Well in the absence of ‘silver bullet’ cures, then the world needs to shift more towards preventative medicine. Alongside providing patients (where possible) with effective tools to take greater control of their own long term care.
I say this as a Crohn’s sufferer myself. Indeed after exhausting all options (eg Humira), I now treat my IBD through resilience techniques, such as those offered by Trellus Health.
A deep science based telemedicine firm that IPO’d in May’21 raising £28.5m at 40p. In order to commercialise its proprietary, resilience/AI led chronic disease management platform - initially focused on IBD.
Today Trellus Health said a new ‘peer-reviewed' document confirmed that by using its technology.
High risk IBD sufferers (394 sample) not only enjoyed improved resilience (59%), fewer A&E visits (71%) and lower unplanned hospitalisations (94%). But also saw significant decreases in opioid (49%) & corticosteroid (73%) use.
Indicating Trellus' platform has the potential to both transform the quality of life of IBD sufferers, and provide help to other long term chronically sick patients.
Lead author Dr. Laurie Keefer, PhD commenting: "Awareness of the importance of treating the whole person when it comes to chronic disease continues to grow."
"Resilience training works when offered in the setting of quality IBD medical care. When we do not separate physical & mental health, patients can take back control and improve their own outcomes, significantly reducing the need for emergency care &d living their best lives."
CEO Monique Fayad adding: "This will not only lead to improvements in health & quality of life, but also drive significant expense reductions associated with costly unplanned care."
